Home/Filings/SCHEDULE 13G/A/0001104659-25-014185
SCHEDULE 13G/A//SEC Filing

AN2 Therapeutics, Inc. SCHEDULE 13G/A

Accession 0001104659-25-014185

CIK 0001965619other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:30 PM ET

Size

6.6 KB

Accession

0001104659-25-014185

Issuer

Brii Biosciences Ltd

CIK 0001965619

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001965619

Filing Metadata

Form type
SCHEDULE 13G/A
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:30 PM ET
Size
6.6 KB